Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samer Al-Saad

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|June 2, 2015
Cancer-associated fibroblasts from lung tumors maintain their immunosuppressive abilities after high-dose irradiationLaia Gorchs, Turid Hellevik, Jack-Ansgar Bruun, et al.
Plos One|July 26, 2017
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancerSamer Al-Saad, Elin Richardsen, Thomas K Kilvaer, et al.
BMC Clinical Pathology|February 15, 2014
High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcomeHelge Stenvold, Tom Donnem, Sigve Andersen, et al.
The Prostate|August 12, 2014
Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancerNora Ness, Sigve Andersen, Andrej Valkov, et al.
Lung Cancer (Amsterdam, Netherlands)|February 7, 2013
CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapySigurd M Hald, Roy M Bremnes, Khalid Al-Shibli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancerRoy M Bremnes, Tom Dønnem, Samer Al-Saad, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 22, 2010
The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancerRoy M Bremnes, Khalid Al-Shibli, Tom Donnem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancerTom Donnem, Samer Al-Saad, Khalid Al-Shibli, et al.
Oncotarget|October 7, 2016
Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancerMehrdad Rakaee, Lill-Tove Busund, Erna-Elise Paulsen, et al.
Steroids|December 24, 2017
Corrigendum to "Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer" [Steroids 113 (2016) 5-13]Kaja Skjefstad, Thea Grindstad, Mehrdad Rakaee Khanehkenari, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|June 2, 2015
Cancer-associated fibroblasts from lung tumors maintain their immunosuppressive abilities after high-dose irradiationLaia Gorchs, Turid Hellevik, Jack-Ansgar Bruun, et al.
Plos One|July 26, 2017
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancerSamer Al-Saad, Elin Richardsen, Thomas K Kilvaer, et al.
BMC Clinical Pathology|February 15, 2014
High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcomeHelge Stenvold, Tom Donnem, Sigve Andersen, et al.
The Prostate|August 12, 2014
Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancerNora Ness, Sigve Andersen, Andrej Valkov, et al.
Lung Cancer (Amsterdam, Netherlands)|February 7, 2013
CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapySigurd M Hald, Roy M Bremnes, Khalid Al-Shibli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancerRoy M Bremnes, Tom Dønnem, Samer Al-Saad, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 22, 2010
The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancerRoy M Bremnes, Khalid Al-Shibli, Tom Donnem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancerTom Donnem, Samer Al-Saad, Khalid Al-Shibli, et al.
Oncotarget|October 7, 2016
Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancerMehrdad Rakaee, Lill-Tove Busund, Erna-Elise Paulsen, et al.
Steroids|December 24, 2017
Corrigendum to "Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer" [Steroids 113 (2016) 5-13]Kaja Skjefstad, Thea Grindstad, Mehrdad Rakaee Khanehkenari, et al.
Pageof 6